Continuous Renal Replacement Therapy: A Review of Use and Application in Pediatric Hematopoietic Stem Cell Transplant Recipients

Hematopoietic stem cell transplant (HSCT) is a curative therapy for malignant and non-malignant conditions. However, complications post-HSCT contribute to significant morbidity and mortality in this population. Acute kidney injury (AKI) is common in the post-allogeneic transplant phase and contribut...

Full description

Bibliographic Details
Main Authors: Lama Elbahlawan, John Bissler, R. Ray Morrison
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.632263/full
id doaj-2f2b957b9935481f873c28a1c9943a90
record_format Article
spelling doaj-2f2b957b9935481f873c28a1c9943a902021-02-26T07:41:20ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-02-011110.3389/fonc.2021.632263632263Continuous Renal Replacement Therapy: A Review of Use and Application in Pediatric Hematopoietic Stem Cell Transplant RecipientsLama Elbahlawan0John Bissler1John Bissler2R. Ray Morrison3Division of Critical Care Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United StatesDepartment of Pediatrics, University of Tennessee Health Science Center and Le Bonheur Children’s Hospital, Memphis, TN, United StatesDepartment of Pediatrics, St. Jude Children’s Research Hospital, Memphis, TN, United StatesDivision of Critical Care Medicine, St. Jude Children’s Research Hospital, Memphis, TN, United StatesHematopoietic stem cell transplant (HSCT) is a curative therapy for malignant and non-malignant conditions. However, complications post-HSCT contribute to significant morbidity and mortality in this population. Acute kidney injury (AKI) is common in the post-allogeneic transplant phase and contributes to morbidity in this population. Continuous renal replacement therapy (CRRT) is used often in the setting of AKI or multiorgan dysfunction in critically ill children. In addition, CRRT can be useful in many disease processes related to transplant and can potentially improve outcomes in this population. This review will focus on the use of CRRT in critically ill children in the post-HSCT setting outside the realm of acute renal failure and highlight the benefits and applications of this modality in this high-risk population.https://www.frontiersin.org/articles/10.3389/fonc.2021.632263/fullcontinuous renal replacement therapy (CRRT)renal replacement therapyhematopoietic (stem) cell transplantation (HCST)fluid overloadpediatricsoutcome
collection DOAJ
language English
format Article
sources DOAJ
author Lama Elbahlawan
John Bissler
John Bissler
R. Ray Morrison
spellingShingle Lama Elbahlawan
John Bissler
John Bissler
R. Ray Morrison
Continuous Renal Replacement Therapy: A Review of Use and Application in Pediatric Hematopoietic Stem Cell Transplant Recipients
Frontiers in Oncology
continuous renal replacement therapy (CRRT)
renal replacement therapy
hematopoietic (stem) cell transplantation (HCST)
fluid overload
pediatrics
outcome
author_facet Lama Elbahlawan
John Bissler
John Bissler
R. Ray Morrison
author_sort Lama Elbahlawan
title Continuous Renal Replacement Therapy: A Review of Use and Application in Pediatric Hematopoietic Stem Cell Transplant Recipients
title_short Continuous Renal Replacement Therapy: A Review of Use and Application in Pediatric Hematopoietic Stem Cell Transplant Recipients
title_full Continuous Renal Replacement Therapy: A Review of Use and Application in Pediatric Hematopoietic Stem Cell Transplant Recipients
title_fullStr Continuous Renal Replacement Therapy: A Review of Use and Application in Pediatric Hematopoietic Stem Cell Transplant Recipients
title_full_unstemmed Continuous Renal Replacement Therapy: A Review of Use and Application in Pediatric Hematopoietic Stem Cell Transplant Recipients
title_sort continuous renal replacement therapy: a review of use and application in pediatric hematopoietic stem cell transplant recipients
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2021-02-01
description Hematopoietic stem cell transplant (HSCT) is a curative therapy for malignant and non-malignant conditions. However, complications post-HSCT contribute to significant morbidity and mortality in this population. Acute kidney injury (AKI) is common in the post-allogeneic transplant phase and contributes to morbidity in this population. Continuous renal replacement therapy (CRRT) is used often in the setting of AKI or multiorgan dysfunction in critically ill children. In addition, CRRT can be useful in many disease processes related to transplant and can potentially improve outcomes in this population. This review will focus on the use of CRRT in critically ill children in the post-HSCT setting outside the realm of acute renal failure and highlight the benefits and applications of this modality in this high-risk population.
topic continuous renal replacement therapy (CRRT)
renal replacement therapy
hematopoietic (stem) cell transplantation (HCST)
fluid overload
pediatrics
outcome
url https://www.frontiersin.org/articles/10.3389/fonc.2021.632263/full
work_keys_str_mv AT lamaelbahlawan continuousrenalreplacementtherapyareviewofuseandapplicationinpediatrichematopoieticstemcelltransplantrecipients
AT johnbissler continuousrenalreplacementtherapyareviewofuseandapplicationinpediatrichematopoieticstemcelltransplantrecipients
AT johnbissler continuousrenalreplacementtherapyareviewofuseandapplicationinpediatrichematopoieticstemcelltransplantrecipients
AT rraymorrison continuousrenalreplacementtherapyareviewofuseandapplicationinpediatrichematopoieticstemcelltransplantrecipients
_version_ 1724249786942488576